Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 10, Issue 4, 2009, Pages 241-246

  Sierra Díaz, Erick ^a   Sánchez Corona, José ^b,c   Rosales Gómez, Roberto Carlos ^b,c   Gutierrez Rubio, Susan Andrea ^a   Vázquez Camacho, José Gonzalo ^a   Solano Moreno, Héctor ^a   Morán Moguel, María Cristina ^b  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Benign prostatic hyperplasia; Polymorphisms; Prostate cancer; Renin angiotensin system

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSIN TYPE 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROSTATE CANCER; PROSTATE HYPERTROPHY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR;

GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTOR, ANGIOTENSIN, TYPE 1; SEQUENCE DELETION;

EID: 73349095075     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320309352800     Document Type: Article

References (20)

1. Secretaria de Salud. Registro Histopatológico de Neoplasias Malignas/Compendio Mortalidad/Morbilidad 2003 (RHNM 03). México ; 2003.
2. Instituto Nacional de Estadä?stica Geografä?a e Informática (INEGI). Mortalidad en México 2000-2001. México: Secretarä?a de Salud ; 2002.
3. Klein EA, Platz E., Thompson I. Epidemiology, etiology and prevention of prostate cancer. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW and Peters CA (eds.). Campbell-Walsh Urology. Philadelphia: Saunders Elsevier, 2007 ; 2854-2873.
4. Steinberg GD, Carter BS, Beaty TH, Childs B., Walsh PC Family history and the risk of prostate cancer. Prostate 1990 ; 17: 337-347.
5. Carter BS, Beaty TH, Steinberg GD, Childs B., Walsh PC Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A 1992 ; 89: 3367-3371.
6. Simard J., Dumont M., Soucy P., Labrie F. Perspective: prostate cancer susceptibility genes. Endocrinology 2002 ; 143: 2029-2040.
7. Gonzalgo ML, Isaacs WB Molecular pathways to prostate cancer. J Urol 2003 ; 170: 2444-2452.
8. Cansino Alcaide JR, Martä?nez-Piä±eiro L. Molecular biology in prostate cancer. Clin Transl Oncol 2006 ; 8: 148-152.
9. Bosch TM, Meijerman I., Beijnen JH, Schellens JH Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clin Pharmacokinet 2006 ; 45: 253-285. (Pubitemid 43327492)
10. Shibata A., Stamey TA, McNeal JE, Cheng I., Peehl DM Genetic polymorphisms in the androgen receptor and type II 5alpha-reductase genes in prostate enlargement. J Urol 2001 ; 166: 1560-1564.
11. Keshava C., McCanlies EC, Weston A. CYP3A4 polymorphisms-potential risk factors for breast and prostate cancer: a HuGE review. Am J Epidemiol 2004 ; 160: 825-841.
12. Bader M., Peters J., Baltatu O., Mä»ller DN, Luft FC, Ganten D. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 2001 ; 79 (2-3). 76-102.
13. Lavoie JL, Sigmund CD Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 2003 ; 144: 2179-2183.
14. Uemura H., Ishiguro H., Kubota Y. Angiotensin II receptor blocker: possibility of antitumor agent for prostate cancer. Mini Rev Med Chem 2006 ; 6: 835-844.
15. Oĝ€™Mahony OA, Barker S., Puddefoot JR, Vinson GP Synthesis and secretion of angiotensin II by the prostate gland in vitro. Endocrinology 2005 ; 146: 392-398.
16. Yigit B., Bozkurt N., Narter F., Yilmaz H., Yucebas E., Isbir T. Effects of ACE I/D polymorphisms on prostate cancer risk, tumor grade and metastasis. Anticancer Res 2007 ; 27: 933-936.
17. Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985 ; 130: 118-126.
18. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphisms of the human angiotensin converting enzyme (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992 ; 20: 1433.
19. Jeunemaitre X., Ledru F., Battaglia S. et al. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease. The CORGENE study. Hum Genet 1997 ; 99 (1). 66-73.
20. Strom TM, Wienker TF Hardy-Weinberg Test. Available at http://ihg.gsf.de/cgi-bin/hw/hwa1.pl (accessed November 2007 ).